Author details

Full Name

Milan G Chheda

Affiliation

ORCID

Career Start Year

1996

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36917417	Trajectories of participation in daily life among individuals newly diagnosed with cancer: A 5-month longitudinal study.	Support Care Cancer	2023
37668941	Predicting survival in glioblastoma with multimodal neuroimaging and machine learning.	J Neurooncol	2023
37914932	Epigenetic regulation during cancer transitions across 11 tumour types.	Nature	2023
37961519	Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages.	bioRxiv	2023
37554225	A pilot phase Ib study to evaluate tadalafil to overcome immunosuppression during chemoradiotherapy for IDH-wild-type glioblastoma.		2023
36973268	Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma.	Nat Commun	2023
37208361	Using mass spectrometry imaging to map fluxes quantitatively in the tumor ecosystem.		2023
37198186	Author Correction: Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma.	Nat Commun	2023
36634606	NCCN GuidelinesÂ® Insights: Central Nervous System Cancers, Version 2.2022.	J Natl Compr Canc Netw	2023
35031547	Long-Acting Recombinant Human Interleukin-7, NT-I7, Increases Cytotoxic CD8 T Cells and Enhances Survival in Mouse Glioma Models.	Clin Cancer Res	2022
35505674	Corrigendum to: A phase II study of laser interstitial thermal therapy combined with doxorubicin in patients with recurrent glioblastoma.	Neurooncol Adv	2022
35995947	Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer.	Nat Genet	2022
35601970	A randomized feasibility study evaluating temozolomide circadian medicine in patients with glioma.	Neurooncol Pract	2022
35088051	Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trial.	Neurooncol Adv	2021
33862619	Re-evaluating Biopsy for Recurrent Glioblastoma: A Position Statement by the Christopher Davidson Forum Investigators.	Neurosurgery	2021
34007966	The state of neuro-oncology during the COVID-19 pandemic: a worldwide assessment.	Neurooncol Adv	2021
33577785	Proteogenomic and metabolomic characterization of human glioblastoma.	Cancer Cell	2021
34345818	Salvage therapies for radiation-relapsed isocitrate dehydrogenase-mutant astrocytoma and 1p/19q codeleted oligodendroglioma.	Neurooncol Adv	2021
33232299	Zika virus oncolytic activity requires CD8+ T cells and is boosted by immune checkpoint blockade.	JCI Insight	2021
33400685	Defining phenotypic and functional heterogeneity of glioblastoma stem cells by mass cytometry.	JCI Insight	2021
34988450	A phase II study of laser interstitial thermal therapy combined with doxorubicin in patients with recurrent glioblastoma.	Neurooncol Adv	2021
31711239	Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas.	Neuro Oncol	2020
32227231	A Fyn romance: tumor cell Fyn kinase suppresses the immune microenvironment.	Neuro-Oncology	2020
30872624	CHD4 regulates the DNA damage response and RAD51 expression in glioblastoma.	Scientific Reports	2019
31803366	The impact of systemic precision medicine and immunotherapy treatments on brain metastases.	Oncotarget	2019
29320744	Consumption of NADPH for 2-HG Synthesis Increases Pentose Phosphate Pathway Flux and Sensitizes Cells to Oxidative Stress.	Cell Rep	2018
27844308	Impact of concurrent chemotherapy with radiation therapy for elderly patients with newly diagnosed glioblastoma: a review of the National Cancer Data Base.	Journal of Neuro-Oncology	2017
28916645	Correction: Zika virus has oncolytic activity against glioblastoma stem cells.	J Exp Med	2017
28486100	Using Epigenetic Reprogramming to Treat Pediatric Brain Cancer.	Cancer Cell	2017
28874392	Zika virus has oncolytic activity against glioblastoma stem cells.	J Exp Med	2017
25503302	Vandetanib plus sirolimus in adults with recurrent glioblastoma: results of a phase I and dose expansion cohort study.	J Neurooncol	2015
24440720	ZFHX4 interacts with the NuRD core member CHD4 and regulates the glioblastoma tumor-initiating cell state.	Cell Rep	2014
23074196	Integrative functional genomics identifies RINT1 as a novel GBM oncogene.	Neuro Oncol	2012
22508724	Emerging insights into the molecular and cellular basis of glioblastoma.	Genes Dev	2012
22588883	Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors.	Cancer Discov	2012
22290264	Studying a complex tumor: potential and pitfalls.	Cancer J	2012
20478531	PLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomas.	Cancer Cell	2010
20534551	Pattern of retinoblastoma pathway inactivation dictates response to CDK4/6 inhibition in GBM.	Proc Natl Acad Sci U S A	2010
18794900	CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity.	Nature	2008
17372135	Hepatitis B reactivation during glioblastoma treatment with temozolomide: a cautionary note.	Neurology	2007
12605097	Two NOTCH4 polymorphisms and their relation to schizophrenia susceptibility and different personality traits.	Psychiatric Genetics	2003
11283605	Phosphorylation of Snapin by PKA modulates its interaction with the SNARE complex.	Nature Cell Biology	2001
8927105	Cardiopulmonary resuscitation on television.	New England Journal of Medicine	1996